MedTrace Logo

Study to Evaluate the Efficacy of Blue Fenugreek Kale Extract (BFKE) on Skin

NCT04544982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-04-06

No results posted yet for this study

Summary

Participants will be supplemented BFKE for a period of 8-weeks to improve skin health. The objective of the study is to evaluate the 'Transepidermal Water Loss (TEWL)' that characterizes the skin barrier function of stratum corneum. Additional parameters include, evaluation of skin moisture content, wrinkling, elasticity, sagging, radiance and also on inflammatory biomarkers.

Conditions

  • Skin Health

Interventions

OTHER

Blue fenugreek kale extract

One capsule to be taken orally before breakfast and one capsule after lunch, with water.

OTHER

Placebo

One capsule to be taken orally before breakfast and one capsule after lunch, with water.

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-01-30
Completion
2021-03-25

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04544982 on ClinicalTrials.gov